ABBOTT LABORATORIES (ABT) revenue & profit
ABBOTT LABORATORIES (ABT): revenue $44.3B, net income $6.5B in 2025; latest quarter +13% year over year. From SEC filings.
$44.3BRevenue 2025
TickerABT (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$44.3B
Net income 2025$6.5B
Net margin14.7%
Annual revenue growth+5.7%
Latest quarter (2026 Q2) · Revenue$12.6B
vs. same quarter last year+13%
Latest quarter · Net income$928M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $43.7B | $6.9B | |
| 2023 | $40.1B | $5.7B | |
| 2024 | $42B | $13.4B | |
| 2025 | $44.3B | $6.5B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.